Hepatoprotective effect of juglone on dimethylnitrosamine‑induced liver fibrosis and its effect on hepatic antioxidant defence and the expression levels of α‑SMA and collagen III

Zhou,De‑Jiang; Mu,Dong; Jiang,Ming‑De; Zheng,Shu‑Mei; Zhang,Yong; He,Sheng; Weng,Min; Zeng,Wei‑Zheng

doi:10.3892/mmr.2015.3992

Hepatoprotective effect of juglone on dimethylnitrosamine‑induced liver fibrosis and its effect on hepatic antioxidant defence and the expression levels of α‑SMA and collagen III

Authors:
- De‑Jiang Zhou
- Dong Mu
- Ming‑De Jiang
- Shu‑Mei Zheng
- Yong Zhang
- Sheng He
- Min Weng
- Wei‑Zheng Zeng
View Affiliations

Affiliations: Internal Medicine Department of Digestion, General Hospital of Chengdu Military Region, Chengdu, Sichuan 610083, P.R. China
Published online on: June 24, 2015 https://doi.org/10.3892/mmr.2015.3992
Pages: 4095-4102
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the antifibrotic effects of juglone on dimethylnitrosamine (DMN)‑induced fibrosis in rats. Juglone, which is a quinone, significantly decreased DMN‑induced rat hepatic fibrosis, which was associated with increased superoxide dismutase (SOD) activity, decreased oxidative stress and reduced levels of α‑smooth muscle actin (α‑SMA) and collagen (Col) III in the liver. Serum levels of alanine aminotransferase, aspartate aminotransferase, hyaluronic acid, laminin, type III precollagen and type IV collagen were significantly reduced by treatment with juglone. Liver fibrosis was induced in male Sprague‑Dawley rats by subcutaneous injections of DMN solution and hepatic fibrosis was assessed using Massons trichome staining. The expression levels of α‑SMA and Col III were determined using immunohistochemical techniques. The activities of SOD and malondialdehyde in liver homogenates were also determined. The results suggested that juglone augmented the antioxidative capability of the liver, possibly by stimulating the activity of SOD, which promoted the inactivation of hepatic stellate cells (HSCs) and decreased the accumulation of extracellular matrix collagen in the liver, thereby alleviating hepatic fibrosis. Silymarin was used as a positive control for liver fibrosis protection. It was hypothesized that juglone alleviates or mitigates oxidative stress‑mediated hepatic fibrosis by upregulating the expression of peroxisome proliferator‑activated receptor γ and inhibiting the activation of HSC.

View Figures

View References

1	Friedman SL: Liver fibrosis-from bench to bedside. J Hepatol. 38(Suppl 1): 38–53. 2003. View Article : Google Scholar
2	Bataller R and Brenner DA: Liver fibrosis. J Clin Invest. 115:209–218. 2005. View Article : Google Scholar : PubMed/NCBI
3	Gines P, Cardenas A, Arroyo V and Rodes J: Management of cirrhosis and ascites. N Engl J Med. 350:1646–1654. 2004. View Article : Google Scholar : PubMed/NCBI
4	Friedman SL: Liver firosis - from bench to bedside. J Hepatol. 38(Suppl 1): S38–S53. 2003. View Article : Google Scholar
5	Chen SL and Morgan TR: The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 3:47–52. 2006. View Article : Google Scholar : PubMed/NCBI
6	Soyer MT, Ceballos R and Aldrete JS: Reversibility of severe hepatic damage caused by jejunoileal bypass after re-establishment of normal intestinal continuity. Surgery. 79:601–604. 1976.PubMed/NCBI
7	Friedman SL, Roll FJ, Boyles J and Bissell DM: Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. ProcNatlAcadSci USA. 82:8681–8685. 1985. View Article : Google Scholar
8	Geerts A: History, heterogeneity, developmental biology and functions of quiescent hepatic stellate cells. Semin Liver Dis. 21:311–335. 2001. View Article : Google Scholar : PubMed/NCBI
9	Li D and Friedman SL: Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J GastroenterolHepatol. 14:618–633. 1999.
10	Tsukada S, Parsons CJ and Rippe RA: Mechanisms of liver fibrosis. ClinChimActa. 364:33–60. 2006.
11	Wu J and Zern MA: Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol. 35:665–672. 2000. View Article : Google Scholar : PubMed/NCBI
12	Bataller R and Brenner DA: Liver fibrosis. J Clin Invest. 115:209–218. 2005. View Article : Google Scholar : PubMed/NCBI
13	Lee MK, Ha NR, Yang H, Sung SH, Kim GH and Kim YC: Antiproliferative activity of triterpenoids from Ecliptaprostrata on hepatic stellate cells. Phytomedicine. 15:775–780. 2008. View Article : Google Scholar
14	Cichoz-Lach H and Michalak A: Oxidative stress as a crucial factor in liver diseases. World J Gastroenterol. 20:8082–8091. 2014. View Article : Google Scholar : PubMed/NCBI
15	Tahan V, Ozaras R, Canbakan B, et al: Melatonin reduces dimethylnitrosamine-induced liver fibrosis in rats. J Pineal Res. 37:78–84. 2004. View Article : Google Scholar : PubMed/NCBI
16	Poli G: Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med. 21:49–98. 2000. View Article : Google Scholar : PubMed/NCBI
17	Li Q, Zhao XL, Sun J, Jiang SG and Gong XF: Anti-proliferative and apoptosis-inducing activities of juglone in LS-174T cells. Bangladesh J Pharmacol. 8:65–72. 2013. View Article : Google Scholar
18	Aithal BK, Kumar MR, Rao BN, Udupa N and Rao BS: Juglone, a naphthoquinone from walnut, exerts cytotoxic and genotoxic effects against cultured melanoma tumor cells. Cell BiolInt. 33:1039–1049. 2009.
19	Thomson RH: Naturally Occurring Quinones. Academic Press; New York, NY: pp. 257–276. 1971
20	Seshadri P, Rajaram A and Rajaram R: Plumbagin and juglone induce caspase-3-dependent apoptosis involving the mitochondria through ROS generation in human peripheral blood lymphocytes. Free RadicBiol Med. 51:2090–2107. 2011. View Article : Google Scholar
21	Funt RC and Martin J: Black walnut toxicity to plants, humans and horses. Ohio State University Extension Fact sheet HYG-1148-93; 1993
22	Ji YB, Qu ZY and Zou X: Juglone-induced apoptosis in human gastric cancer SGC-7901 cells via the mitochondrial pathway. ExpToxicolPathol. 63:69–78. 2011.
23	Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagent. J BiolChem. 193:265–275. 1951.
24	Jiao J, Friedman SL and Aloman C: Hepatic fibrosis. CurrOpinGastroenterol. 25:223–229. 2009.
25	Ruehl M, Muche M, Freise C, et al: Hydroxyproline-containing collagen analogs trigger the release and activation of collagen-sequestered proMMP-2 by competition with prodomain-derived peptide P33-42. Fibrogenesis Tissue Repair. 4:12011. View Article : Google Scholar : PubMed/NCBI
26	Chen JC, Tsai CC, Chen LD, Chen HH and Wang WC: Therapeutic effect of gypenoside on chronic liver injury and fibrosis induced by CC14 in rats. Am J Chin Med. 28:175–185. 2000. View Article : Google Scholar
27	Meng Z, Wang Y, Wang L, et al: FXR regulates liver repair after CC14-induced toxic injury. MolEndocrinol. 24:886–897. 2010.
28	Giannini EG, Testa R and Savarino V: Liver enzyme alteration: A guide for clinicians. CMAJ. 172:367–379. 2005. View Article : Google Scholar : PubMed/NCBI
29	Radosavljevic T, Mladenovic D and Vucevic D: The role of oxidative stress in alcoholic liver injury. Med Pregl. 62:547–553. 2009.In Serbian. View Article : Google Scholar
30	Casini A, Ceni E, Salzano R, et al: Neutrophil derived superoxide anion induceslipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide. Hepatology. 25:361–367. 1997. View Article : Google Scholar : PubMed/NCBI
31	Nieto N, Friedman SL and Cederbaum AI: Cytochrome P450 2El-derived reactive oxygen species mediate paracrine stimulation of collagen I protein synthesis byhepatic stellate cells. J BiolChem. 277:9853–9864. 2002.
32	SvegliatiBaroni G, D'Ambrosio L, Ferretti G, et al: Fibrogenic effect of oxidative stress on rat hepatic stellate cells. Hepatology. 27:720–726. 1998. View Article : Google Scholar
33	Campbell JS, Hughes SD, Gilbertson DG, et al: Platelet derived growth factor C induces liver fibrosis, steatosis and Hepatocellular carcinoma. ProcNatlAcadSci USA. 102:3389–3394. 2005. View Article : Google Scholar
34	Friedman SL: Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J BiolChem. 275:2247–2250. 2000.
35	Wang YD, Jia LW and Li CM: Hepatic content of collagens and laminin in rat model of experimental liver fibrosis. World J Gastroenterol. 6:732000.
36	Islam S, Antonsson L, Westin J and Lagging M: Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers. Scand J Gastroenterol. 40:867–872. 2005. View Article : Google Scholar : PubMed/NCBI